MV CAPITAL MANAGEMENT, INC.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1633366
BETHESDA, MD
Position in VRTX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$104,313
-$10,447 QoQ
Shares Held
210
-18.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,467
of 1,730 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $228,442 across 29 Biotechnology names. VRTX ranks #1 (45.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
210 | $104,313 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
61 | $38,035 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
66 | $19,867 | |
| 4 | INCY |
Incyte Corp
|
113 | $12,809 | |
| 5 | MRNA |
Moderna, Inc.
|
124 | $8,683 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
90 | $7,335 | |
| 7 | RPRX |
Royalty Pharma plc
|
124 | $6,952 | |
| 8 | CYTK |
Cytokinetics Inc
|
71 | $6,048 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,313 | 210 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $114,760 | 257 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $85,685 | 189 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $72,845 | 186 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $87,259 | 196 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $196,836 | 406 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $78,929 | 196 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $89,295 | 192 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $89,994 | 192 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $76,495 | 183 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $79,343 | 195 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $62,245 | 179 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $59,120 | 168 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $49,781 | 158 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $42,450 | 147 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $42,272 | 146 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $34,378 | 122 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $32,099 | 123 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $20,203 | 92 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $15,599 | 86 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,016 | 10 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,504 | 7 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||